Tags Biotechnology
Related Insights
Thu 17 Aug 2023
AI and Drug Repurposing: Farewell, serendipity?
Our pledge to make therapies available for patients, faster, and why Artificial Intelligence is the key for small molecule repurposing
Tue 23 Aug 2022
Using Zeptomics for hit discovery
Learn more about the performance of ZeptoHit, the hit prediction algorithm of Zeptomics
Fri 29 Apr 2022
ADMET prediction with Artificial Intelligence : Publication
Peer reviewed publication "Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination"
Mon 14 Mar 2022
Artificial Intelligence for Targeted Protein Degradation
Discover how Kantify’s AI -based drug discovery tool, Zeptomics, accelerates the discovery of promising Targeted Protein Degraders (PROTAC, DUBTAC, LYTAC,...),
Wed 26 Jan 2022
Machine learning for in-silico lead identification
Discover how AI can help you select promising lead compounds through predicting their ADMET properties and off-target side effects
Thu 27 May 2021
Key AI Techniques in small molecule screening
Discover the key Artificial Intelligence techniques used for small molecule screening
Related News
Thu 15 Jun 2023
Presentation at Cafes de L'Innovation
Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet
Tue 06 Jun 2023
Kantify Nominated as Early Startup to Watch by Sifted
We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report
Fri 03 Mar 2023
Upcoming talk: in silico drug discovery and animal testing
Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"
Tue 28 Feb 2023
When AI meets Stem Cells: spotlight on our work with I-Stem
Kantify and I-Stem work together for faster rare disease drug discovery
Mon 06 Feb 2023
Special edition on Artificial Intelligence in La Libre Eco
Kantify in the special edition of La Libre Eco on Artificial Intelligence
Sun 05 Feb 2023
Kantify' CEO interview on TV LN24
Kantify's CEO was invited as "CEO of the week" by Bruno Wattenbergh on LN24
Thu 27 Oct 2022
Belgian AI Strategy: Kantify joins State Secretary
State Secretary Mathieu Michel invited us to illustrate the power of AI in Health at UCB for the launch event of the Belgian AI plan
Mon 17 Oct 2022
Kantify & Mcule harness data to accelerate drug discovery
Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction
Tue 09 Aug 2022
Kantify in BX1 show on startups and Artificial Intelligence
Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence
Mon 02 May 2022
Register to our webinar : Targeted Protein Degraders and AI
Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.
Sat 30 Apr 2022
Webinar replay : AI for in silico drug discovery
Watch the replay of our webinar on Zeptomics, Kantify solution for in silico drug discovery
Wed 27 Apr 2022
New discovery with I-Stem (Press Release)
Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease
Wed 13 Apr 2022
Abstract selected for Knowledge For Growth
The Abstract presents how AI can be used to accelerate and derisk lead optimization by predicting ADMET properties and off-target binding scores
Mon 28 Mar 2022
Kantify at the annual event of Brussels' Healthtech cluster
Kantify is speaking at the annual event of the Brussels cluster of healthtech companies
Tue 22 Mar 2022
Unveiling Zeptomics, Kantify’s AI drug discovery technology
Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery
Thu 30 Sep 2021
European Biotech Week: webinar on AI for Drug Discovery
Kantify hosted its first webinar titled Artificial Intelligence for Drug Discovery and Development, as a part of the European Biotechnology Week 2021
Wed 01 Sep 2021
Kantify at the European Biotech Week: AI for Drug Discovery
Kantify is hosting a virtual event during European Biotech Week titled: Artificial Intelligence in drug discovery and development
Tue 24 Aug 2021
Kantify announces new upgrades on ZeptoNet
Kantify announces new upgrades on ZeptoNet - its AI technology for drug discovery
Thu 22 Jul 2021
Kantify joins the European Biotechnology Network
Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences
Mon 10 May 2021
Kantify joins Data-driven Advanced Therapeutics Accelerator
Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst
Wed 14 Apr 2021
The CEO of Kantify interviews with DataNews
The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry
Wed 24 Mar 2021
European Commission Report on AI Uptake in Healthcare
The European Commission publishes a report to monitor the development, uptake and impact of Artificial Intelligence for healthcare.
Fri 19 Mar 2021
Kantify announces its new drug discovery technology
Kantify announces ZeptoNet, its new Virtual screening technology of small molecules
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.
Related Technologies
Fri 10 Mar 2023
Artificial Intelligence for Targeted Protein Degradation
Discover Zepto.Degrader, Kantify's solution for Targeted Protein Degrader discovery using Artificial Intelligence
Fri 10 Mar 2023
Artificial Intelligence solution for ADMETox prediction
Discover our next generation AI solution for discovery of absorption, distribution, metabolism, excretion, and toxicity properties
Fri 10 Mar 2023
AI solution for in silico small molecule discovery
Discover our next generation AI solution for discovery of hits and bioactivity
Fri 10 Mar 2023
Artificial Intelligence for Target Identification
Discover our next generation AI solution Zepto.Target, which deconvolutes therapeutic targets based on the output of phenotypic screens